Effects of pH upon the inhibition by sulphonylurea drugs of ATP-sensitive K+ channels in cardiac muscle
- PMID: 1625214
Effects of pH upon the inhibition by sulphonylurea drugs of ATP-sensitive K+ channels in cardiac muscle
Abstract
The effect of pH was tested upon the inhibition of ATP-sensitive K+ (KATP) channels caused by the sulphonylurea drugs tolbutamide and glibenclamide. KATP channels and currents (I-KATP) were activated with SR 44866 in ventricular myocytes isolated from guinea pig hearts. Modification of either external or internal pH had little effect upon the background K+ current (IK1). External pH had no consistent effects upon I-KATP. The application of NH4Cl inhibited I-KATP and its withdrawal caused a slight rebound activation. Compared with the results obtained at pHo 7.4, inhibition of I-KATP by the sulphonylurea drugs was enhanced at pHo 6.5 and reduced at pHo 8.4. The kinetics of the recovery of I-KATP was independent of pHo. Neither internal pH 6.5 nor NH4Cl had any effect upon sulphonylurea-induced inhibition of I-KATP. The dose-response curves for inhibition of I-KATP at different pHo's were found to coincide when plotted for the unionized concentrations of the drugs. It is concluded that it is the unionized forms of the sulphonylurea drugs which are responsible for closure of KATP channels in cardiac muscle. In consequence, extracellular acidification during ischemia will increase the effective concentration of glibenclamide and may be responsible for the cardiovascular disorders associated with this treatment in noninsulin-dependent diabetics.
Similar articles
-
Inhibition of ATP-sensitive K+ channels in cardiac muscle by the sulphonylurea drug glibenclamide.J Pharmacol Exp Ther. 1992 May;261(2):540-5. J Pharmacol Exp Ther. 1992. PMID: 1578371
-
Sulphonylurea drugs no longer inhibit ATP-sensitive K+ channels during metabolic stress in cardiac muscle.J Pharmacol Exp Ther. 1993 Jul;266(1):456-67. J Pharmacol Exp Ther. 1993. PMID: 8331572
-
Potassium channel modulation: a new drug principle for regulation of smooth muscle contractility. Studies on isolated airways and arteries.Dan Med Bull. 1996 Dec;43(5):429-47. Dan Med Bull. 1996. PMID: 8960816
-
Cardiovascular effects of sulphonylurea derivatives.Diabetes Res Clin Pract. 1996 Jul;31 Suppl:S55-9. doi: 10.1016/0168-8227(96)01230-2. Diabetes Res Clin Pract. 1996. PMID: 8864641 Review.
-
ATP-sensitive potassium channels in the cerebral circulation.Stroke. 2003 Jun;34(6):1547-52. doi: 10.1161/01.STR.0000070425.98202.B5. Epub 2003 Apr 24. Stroke. 2003. PMID: 12714709 Review.
Cited by
-
Sulfonylurea receptor 1 in central nervous system injury: a focused review.J Cereb Blood Flow Metab. 2012 Sep;32(9):1699-717. doi: 10.1038/jcbfm.2012.91. Epub 2012 Jun 20. J Cereb Blood Flow Metab. 2012. PMID: 22714048 Free PMC article. Review.
-
Drugs acting on SUR1 to treat CNS ischemia and trauma.Curr Opin Pharmacol. 2008 Feb;8(1):42-9. doi: 10.1016/j.coph.2007.10.004. Epub 2007 Nov 26. Curr Opin Pharmacol. 2008. PMID: 18032110 Free PMC article.
-
ATP-sensitive K+ channels are functional in expiratory neurones of normoxic cats.J Physiol. 1996 Jul 15;494 ( Pt 2)(Pt 2):399-409. doi: 10.1113/jphysiol.1996.sp021501. J Physiol. 1996. PMID: 8842000 Free PMC article.
-
Effects of glibenclamide upon ATP-sensitive K channels during metabolic inhibition of isolated rat cardiac myocytes.Cardiovasc Drugs Ther. 1993 Aug;7 Suppl 3:495-7. doi: 10.1007/BF00877613. Cardiovasc Drugs Ther. 1993. PMID: 8251418 Review. No abstract available.
-
Sulfonylurea Receptor 1 in Central Nervous System Injury: An Updated Review.Int J Mol Sci. 2021 Nov 2;22(21):11899. doi: 10.3390/ijms222111899. Int J Mol Sci. 2021. PMID: 34769328 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Research Materials